Torl Biotherapeutics, Llc
Clinical trials sponsored by Torl Biotherapeutics, Llc, explained in plain language.
-
New drug TORL-3-600 tested in advanced cancer patients for first time
Disease control OngoingThis early-stage study tests a new drug called TORL-3-600 in 70 adults with advanced solid tumors or colorectal cancer that has not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have…
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
New drug trial offers hope for Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new drug called TORL-2-307-ADC in people with advanced solid tumors, including stomach, pancreas, and esophageal cancers. The main goals are to find a safe dose and check for side effects. About 163 participants will receive the drug to see if it ca…
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 05:01 UTC